Skip to content

Multidimensional Phenotypes, Mechanisms, and Prognostic Impact of Circadian Rhythm Disruption in Patients with Amyotrophic Lateral Sclerosis

Multidimensional Phenotypes, Mechanisms, and Prognostic Impact of Circadian Rhythm Disruption in Patients with Amyotrophic Lateral Sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128451
Enrollment
Unknown
Registered
2026-07-21
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amyotrophic lateral sclerosis

Interventions

Observation group of ALS patients:None
Control group:None

Sponsors

Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for patient enrollment: (1)Age >=18 and <=80 years; (2)Diagnosis of ALS according to the revised El Escorial criteria; (3)Willingness to undergo 7 consecutive days of actigraphy monitoring and a 24-hour ambulatory ECG (Holter) recording; (4)Willingness to provide saliva, urine, and blood samples; (5)Ability to complete ECAS, ALSFRS-R assessments and pulmonary function testing; (6)Sufficient mobility to cooperate with actigraphy monitoring and complete follow-up. 2.Inclusion criteria for the control group: (1)Age, sex, and years of education matched to the ALS group; (2)No history of neurological disease; (3)No shift work and no trans-time-zone travel within the past month; (4)Willingness to undergo a series of assessments comparable to the ALS group, including actigraphy monitoring, saliva/urine/blood sampling, and 24-hour ambulatory ECG recording.

Exclusion criteria

Exclusion criteria: 1.Use of systemic glucocorticoids or adrenal steroid medications within the past month; 2.Major changes in daily/life rhythm within the past 2 weeks (travel across >=3 time zones,night shifts); 3.Significant uncontrolled endocrine/adrenal disease or hepatic/renal failure; 4.Use of medications or foods that markedly affect circadian rhythms and cannot be discontinued or controlled 5.Recent severe infection or fever (within the past 2 weeks); 6.Dermatologic conditions that do not tolerate electrode attachment; 7.Pregnancy or lactation; 8.Inability to comply with follow-up or presence of severe psychiatric or behavioral disorders; 9. Current or prior treatment with invasive or non-invasive positive pressure ventilation (PPV/NIV).

Design outcomes

Primary

MeasureTime frame
Biomarkers in body fluids;24-hour electrocardiographic parameters;Cycle threshold (Ct) values obtained from PCR;Actigraphy parameters;

Countries

China

Contacts

Public ContactMin Zhang

Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology

mzhang@tjh.tjmu.edu.cn+86 27 83663372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026